Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162871 (
abdominal aortic aneurysm
)
8,664
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
ATG9A
is a multispanning membrane protein required for autophagosome formation. Under basal conditions, neosynthesized
ATG9A
proteins travel to the Golgi apparatus and cycle between the trans-Golgi network and endosomes. In the present work, we searched for molecular determinants involved in the subcellular trafficking of human
ATG9A
in HeLa cells using sequential deletions and point mutations. Deletion of amino acids L(340) to L(354) resulted in the retention of
ATG9A
in the endoplasmic reticulum. In addition, we found that substitution of the L(711)YM(713) sequence (located in the C-terminal region of
ATG9A
) by alanine residues severely impaired its transport through the Golgi apparatus. This defect could be corrected by oligomerization of the mutant protein with co-transfected wild-type
ATG9A
, suggesting that
ATG9A
oligomerization may help its sorting through biosynthetic compartments. Lastly, the study of the consequences of the LYM/
AAA
mutation on the intracellular trafficking of
ATG9A
highlighted that some newly synthesized
ATG9A
can bypass the Golgi apparatus to reach the plasma membrane. Taken together, these findings provide new insights into the intracellular pathways followed by
ATG9A
to reach different subcellular compartments, and into the intramolecular determinants that drive the sorting of this protein.
...
PMID:Molecular determinants that mediate the sorting of human ATG9A from the endoplasmic reticulum. 2731 55